Evolving strategies in the treatment of acute myocardial infarction-induced cardiogenic shock.
Publication/Presentation Date
11-1-2014
Abstract
Despite advances in medical technology and re-vascularization interventions, the mortality rate for cardiogenic shock (CS) following acute myocardial infarction has remained at 50%. The majority of these mortalities are from left ventricular failure resulting in multi-system organ dysfunction. The field of mechanical circulatory support (MCS) has evolved within the past decade, with improved outcomes from extracorporeal membrane oxygenation as well as continuous-flow left ventricular assist devices (CF LVADs). In this paper, we discuss our institutional treatment strategies, the rationale for the protocol development, and our improved outcomes when using MCS in patients with refractory CS following acute myocardial infarction.
Volume
3
Issue
6
First Page
606
Last Page
611
ISSN
2225-319X
Published In/Presented At
Tchantchaleishvili, V., Schubmehl, H., Swartz, M. F., Hallinan, W., & Massey, H. T. (2014). Evolving strategies in the treatment of acute myocardial infarction-induced cardiogenic shock. Annals of cardiothoracic surgery, 3(6), 606–611. https://doi.org/10.3978/j.issn.2225-319X.2014.08.03
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
25512903
Department(s)
Administration and Leadership
Document Type
Article